نتایج جستجو برای: pancreatic targeting

تعداد نتایج: 231256  

Journal: :International journal of oncology 2009
Ivane Abiatari Sonja Gillen Tiago DeOliveira Theresa Klose Kong Bo Nathalia A Giese Helmut Friess Jörg Kleeff

Perineural invasion of tumor cells is a characteristic feature of human pancreatic cancer. Unrevealing the molecular mechanisms that enable cancer cells to invade and grow along nerves is important for the development of novel therapeutic strategies in this disease. We have previously identified transcriptional changes in highly nerve invasive pancreatic cancer cells. Here we further analyzed o...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2016
Stephen Edward Snyder

pancreatic neuroendocrine tumor from a 12-week-old mouse, with tumor β-cells stained red and the surrounding exocrine tissue stained blue. Eliane Cortez et al. found that deleting the gene for platelet-derived growth factor DD (PDGF-DD) delayed tumor growth in a mouse model of pancreatic cancer, and that PDGF-DD stimulated proliferation of pancreatic β-tumor cells by binding to a subset of tumo...

Journal: :Cancer letters 2013
Yiwei Li Dejuan Kong Aamir Ahmad Bin Bao Fazlul H Sarkar

In the past few years, there have been significant advances in the research on cancer stem cells (CSCs). The emerging evidences have demonstrated that CSCs and epithelial-mesenchymal transition (EMT)-type cells, which share molecular characteristics with CSCs, play critical roles in drug resistance, invasion, and metastasis. Pancreatic cancer (PC) has a high mortality due to both intrinsic (de ...

Journal: :The Journal of surgical research 2012
Seth B Krantz Mario A Shields Surabhi Dangi-Garimella Hidayatullah G Munshi David J Bentrem

Pancreatic adenocarcinoma remains among the most lethal of human malignancies. Overall 5-y survival is less than 5%, and only 20% of patients presenting with localized disease amenable to surgical resection. Even in patients who undergo resection, long-term survival remains extremely poor. A major contributor to the aggressiveness of multiple cancers, and pancreatic cancer in particular, is the...

Journal: :Cancer research 2016
David R Driscoll Saadia A Karim Makoto Sano David M Gay Wright Jacob Jun Yu Yusuke Mizukami Aarthi Gopinathan Duncan I Jodrell T R Jeffry Evans Nabeel Bardeesy Michael N Hall Brian J Quattrochi David S Klimstra Simon T Barry Owen J Sansom Brian C Lewis Jennifer P Morton

mTOR signaling controls several critical cellular functions and is deregulated in many cancers, including pancreatic cancer. To date, most efforts have focused on inhibiting the mTORC1 complex. However, clinical trials of mTORC1 inhibitors in pancreatic cancer have failed, raising questions about this therapeutic approach. We employed a genetic approach to delete the obligate mTORC2 subunit Ric...

Journal: :Expert Review of Endocrinology & Metabolism 2017

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید